DSS not seeking petition from HHS on generic GLP-1

Connecticut Inside Investigator – Wednesday, July 1, 2026
By Katherine Revello

Officials at the Connecticut Department of Social Services (DSS) and Gov. Ned Lamont’s office have decided not to submit a petition to the U.S. Department of Health and Human Services (DHHS) seeking to allow the state to enter a contract with a drug manufacturer to produce a generic glucagon-like peptide-1 receptor agonist (GLP-1) for individuals enrolled in state healthcare programs, as is required by a law passed in 2025.

Click here to read the entire article.